Enzymatic Methods for Mutation Detection in Cancer Samples and Liquid Biopsies

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Low-frequency tumor somatic DNA mutations in biopsies impact metastasis, prognosis, treatment, and early cancer detection.
• Undetected mutations can lead to incorrect patient management and missed personalized medicine opportunities.
• Advanced techniques like next-generation sequencing and digital-PCR are effective but resource-intensive.

Purpose of the Study:

• To review traditional and emerging enzymatic methods for detecting low-level DNA mutations.
• To highlight the potential and applications of enzymatic approaches in cancer diagnostics, particularly liquid biopsies.
• To present enzymatic mutation detection as an accessible alternative for low-resource settings.

Main Methods:

• Review of enzymatic mutation detection principles and applications.
• Discussion of recent advancements in enzymatic enrichment and detection technologies.
• Focus on the utility of these methods in the context of liquid biopsy analysis.

Main Results:

• Enzymatic methods provide a simple, affordable, and accessible alternative for low-level mutation detection.
• These techniques can enrich and detect low-frequency DNA alterations effectively.
• Enzymatic approaches show significant potential for personalized medicine and early cancer detection.

Conclusions:

• Enzymatic mutation detection is a valuable tool for cancer diagnostics, especially for liquid biopsies.
• Its simplicity and affordability make it suitable for diverse laboratory settings, including those with limited resources.
• Further development and application of enzymatic methods can enhance cancer patient management and outcomes.